Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
?86.83
 
WKN: A2DKZC / Symbol: VRNA / Name: Verona Pharma / Stock / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Verona Pharma plc Stock

With 20 Buy predictions and not the single Sell prediction the community is currently very high on Verona Pharma plc.
With a target price of 86 € there is potential for a 16929.7% increase which would mean more than doubling the current price of 0.51 € for Verona Pharma plc.

Pros and Cons of Verona Pharma plc in the next few years

Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Prediction Buy
Perf. (%) -
Target price 86.010
Change
Ends at 08.10.26

Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $100.00 price target on the stock.
Ratings data for VRNA provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -
Target price 144.279
Change
Ends at 01.07.26

Verona Pharma PLC American Depositary Share (NASDAQ: VRNA) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $170.00 price target on the stock.
Ratings data for VRNA provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -
Target price 139.152
Change
Ends at 23.06.26

Verona Pharma PLC American Depositary Share (NASDAQ: VRNA) had its price target raised by analysts at Piper Sandler from $76.00 to $160.00. They now have an "overweight" rating on the stock.
Ratings data for VRNA provided by MarketBeat
Show more